- Home
- Publications
- Publication Search
- Publication Details
Title
Lipoprotein‐associated phospholipase A2: The story continues
Authors
Keywords
-
Journal
MEDICINAL RESEARCH REVIEWS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-05-29
DOI
10.1002/med.21597
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction
- (2019) Daniel A. Nation et al. NATURE MEDICINE
- Anticytokine Agents
- (2019) Paul M Ridker CIRCULATION RESEARCH
- Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
- (2018) Emelia J. Benjamin et al. CIRCULATION
- Lipoprotein-associated Phospholipase A2 and Coronary Heart Disease
- (2018) Areti Sofogianni et al. CURRENT PHARMACEUTICAL DESIGN
- Differential expression of Lp-PLA2 in obesity and type 2 diabetes and the influence of lipids
- (2018) Laura Jackisch et al. DIABETOLOGIA
- Lp-PLA2 activity is associated with increased risk of diabetic retinopathy: a longitudinal disease progression study
- (2018) Moneeza K. Siddiqui et al. DIABETOLOGIA
- Impact of tyrosine nitration at positions Tyr307 and Tyr335 on structural dynamics of Lipoprotein-associated phospholipase A 2 –A therapeutically important cardiovascular biomarker for atherosclerosis
- (2018) Arun Bahadur Gurung et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Met117 oxidation leads to enhanced flexibility of cardiovascular biomarker- lipoprotein- associated phospholipase A 2 and reduced substrate binding affinity with platelet-activating factor
- (2018) Arun Bahadur Gurung et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Chronic inhibition of lipoprotein-associated phospholipase A 2 does not improve coronary endothelial function: A prospective, randomized-controlled trial
- (2018) Megha Prasad et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Role of Inflammation in Diabetic Retinopathy
- (2018) Anne Rübsam et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Impact of a non-synonymous Q281R polymorphism on structure of human Lipoprotein-Associated Phospholipase A2 (Lp-PLA2 )
- (2018) Arun B. Gurung et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis
- (2018) Sotirios Tsimikas et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Interaction between nonsynonymous polymorphisms in PLA2G7 gene and smoking on the risk of coronary heart disease in a Chinese population
- (2018) Yunpeng Chi et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Effects of apoC1 genotypes on the hormonal levels, metabolic profile and PAF-AH activity in Chinese women with polycystic ovary syndrome
- (2018) Renjiao Zhang et al. Lipids in Health and Disease
- Oxidized LDL and anti-oxidized LDL antibodies in atherosclerosis – Novel insights and future directions in diagnosis and therapy ,
- (2018) Adam Hartley et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Blood-Brain Barrier Disruption Induced Cognitive Impairment Is Associated With Increase of Inflammatory Cytokine
- (2018) Jieli Geng et al. Frontiers in Aging Neuroscience
- Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome
- (2018) Brian A. Bergmark et al. JAMA Cardiology
- Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases A2
- (2018) Aikaterini Nikolaou et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Platelet-activating factor acetylhydrolases: An overview and update
- (2018) Nozomu Kono et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Diabetes and Hypercholesterolemia Increase Blood-Brain Barrier Permeability and Brain Amyloid Deposition: Beneficial Effects of the LpPLA2 Inhibitor Darapladib
- (2018) Nimish K. Acharya et al. JOURNAL OF ALZHEIMERS DISEASE
- Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice
- (2018) Xuchu Que et al. NATURE
- Amelioration of atherosclerosis in apolipoprotein E-deficient mice by combined RNA interference of lipoprotein-associated phospholipase A2 and YKL-40
- (2018) Hui Zhang et al. PLoS One
- Association of Lipoprotein-Associated Phospholipase A2 with the Prevalence of Nonalcoholic Fatty Liver Disease: A Result from the APAC Study
- (2018) Zhongni Liu et al. Scientific Reports
- Canakinumab for Residual Inflammatory Risk
- (2017) Paul M Ridker EUROPEAN HEART JOURNAL
- Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial
- (2017) Emmanuelle Vidal-Petiot et al. EUROPEAN HEART JOURNAL
- The effect of oxidized phospholipids on phenotypic polarization and function of macrophages
- (2017) Vlad Serbulea et al. FREE RADICAL BIOLOGY AND MEDICINE
- Correlations BetweenLP-PLA2Gene Polymorphisms and Susceptibility and Severity of Acute Pancreatitis in a Chinese Population
- (2017) Min Ma et al. Genetic Testing and Molecular Biomarkers
- Macrophages and Phospholipases at the Intersection between Inflammation and the Pathogenesis of HIV-1 Infection
- (2017) Francesca Spadaro et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Structure-Guided Discovery of Novel, Potent, and Orally Bioavailable Inhibitors of Lipoprotein-Associated Phospholipase A2
- (2017) Qiufeng Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Effect of the R92H and A379V genotypes of platelet-activating factor acetylhydrolase on its enzyme activity, oxidative stress and metabolic profile in Chinese women with polycystic ovary syndrome
- (2017) Renjiao Zhang et al. Lipids in Health and Disease
- Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity
- (2017) W. Joost Lesterhuis et al. NATURE REVIEWS DRUG DISCOVERY
- Lactonase Activity and Lipoprotein-Phospholipase A2 as Possible Novel Serum Biomarkers for the Differential Diagnosis of Autism Spectrum Disorders and Rett Syndrome: Results from a Pilot Study
- (2017) Joussef Hayek et al. Oxidative Medicine and Cellular Longevity
- Effects of overweight and the PLA2G7 V279F polymorphism on the association of age with systolic blood pressure
- (2017) Minjoo Kim et al. PLoS One
- Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib
- (2017) Astrid Yeo et al. PLoS One
- Refining Long-Term Prediction of Cardiovascular Risk in Diabetes – The VILDIA Score
- (2017) Georg Goliasch et al. Scientific Reports
- Endothelial Dysfunction in Children With Obstructive Sleep Apnea Is Associated With Elevated Lipoprotein‐Associated Phospholipase A2 Plasma Activity Levels
- (2017) Leila Kheirandish‐Gozal et al. Journal of the American Heart Association
- Short Sleep Duration, Obstructive Sleep Apnea, Shiftwork, and the Risk of Adverse Cardiovascular Events in Patients After an Acute Coronary Syndrome
- (2017) Laura K. Barger et al. Journal of the American Heart Association
- Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial
- (2017) Patricia Oliveira Guimarães et al. Journal of the American Heart Association
- Inflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial
- (2017) Claes Held et al. Journal of the American Heart Association
- Interleukin‐6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID‐TIMI 52 (Stabilization of Plaque Using Darapladib—Thrombolysis in Myocardial Infarction 52) Trial
- (2017) Christina L. Fanola et al. Journal of the American Heart Association
- The Role of Perivascular Adipose Tissue in Non-atherosclerotic Vascular Disease
- (2017) Tetsuo Horimatsu et al. Frontiers in Physiology
- Systematic evaluation of immune regulation and modulation
- (2017) David F. Stroncek et al. Journal for ImmunoTherapy of Cancer
- Genetic Deficiency of Plasma Lipoprotein-Associated Phospholipase A2 (PLA2G7 V297F Null Mutation) and Risk of Alzheimer's Disease in Japan
- (2017) Beena Koshy et al. JOURNAL OF ALZHEIMERS DISEASE
- Maternal Gestational Diabetes Mellitus increases placental and foetal lipoprotein-associated Phospholipase A2 which might exert protective functions against oxidative stress
- (2017) Carolin Schliefsteiner et al. Scientific Reports
- Associations of MDR1, TBXA2R, PLA2G7 and PEAR1 genetic polymorphisms with the platelet activity in Chinese ischemic stroke patients receiving aspirin therapy
- (2016) Ling-ling Peng et al. ACTA PHARMACOLOGICA SINICA
- Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population
- (2016) Hirotsugu Ueshima et al. ATHEROSCLEROSIS
- Advantages of the lipoprotein-associated phospholipase A2 activity assay
- (2016) Leslie J. Donato et al. CLINICAL BIOCHEMISTRY
- Phospholipase A2 Isoforms as Novel Targets for Prevention and Treatment of Inflammatory and Oncologic Diseases
- (2016) Nagendra Yarla et al. CURRENT DRUG TARGETS
- Activity and distribution of plasma platelet-activating factor acetylhydrolase in women with gestational diabetes mellitus and their neonates
- (2016) Qian Gao et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease
- (2016) Ralph A. H. Stewart et al. EUROPEAN HEART JOURNAL
- No relationship between lipoprotein-associated phospholipase A2, proinflammatory cytokines, and neopterin in Alzheimer's disease
- (2016) S. Savas et al. EXPERIMENTAL GERONTOLOGY
- Evaluation of the safety, pharmacokinetics, pharmacodynamics, and drug-drug interaction potential of GSK2647544 in healthy volunteers
- (2016) Kai Wu et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Phospholipases: at the crossroads of the immune system and the pathogenesis of HIV-1 infection
- (2016) Serena Cecchetti et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Discovery of Potent and Orally Active Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Inhibitors as a Potential Therapy for Diabetic Macular Edema
- (2016) Xinde Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fragment-Based Approach to the Development of an Orally Bioavailable Lactam Inhibitor of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2)
- (2016) Alison J.-A. Woolford et al. JOURNAL OF MEDICINAL CHEMISTRY
- Exploitation of a Novel Binding Pocket in Human Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Discovered through X-ray Fragment Screening
- (2016) Alison J.-A. Woolford et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural and Thermodynamic Characterization of Protein–Ligand Interactions Formed between Lipoprotein-Associated Phospholipase A2 and Inhibitors
- (2016) Qiufeng Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lipoprotein-Associated Phospholipase A 2 Loss-of-Function Variant and Risk of Vascular Diseases in 90,000 Chinese Adults
- (2016) Iona Y. Millwood et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A2 and secretory phospholipase A2 in patients with newly diagnosed type 2 diabetes
- (2016) Xiu-hong Lin et al. Lipids in Health and Disease
- Does plasma membrane lipid composition impact the miRNA-mediated regulation of vascular inflammation?
- (2016) Julia Schumann MEDICAL HYPOTHESES
- Investigation of the Brain Biodistribution of the Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Inhibitor [18F]GSK2647544 in Healthy Male Subjects
- (2016) Mickael Huiban et al. MOLECULAR IMAGING AND BIOLOGY
- Resolution of inflammation: a new therapeutic frontier
- (2016) James N. Fullerton et al. NATURE REVIEWS DRUG DISCOVERY
- Twenty years on: the impact of fragments on drug discovery
- (2016) Daniel A. Erlanson et al. NATURE REVIEWS DRUG DISCOVERY
- Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies
- (2016) Saeid Alinezhad et al. PLoS One
- Lipoprotein-associated phospholipase A2(Lp-PLA2) as a therapeutic target to prevent retinal vasopermeability during diabetes
- (2016) Paul Canning et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- “Association between platelet activating factor acetylhydrolase and diabetic retinopathy: Does inflammation affect the retinal status?”
- (2016) Marilita M. Moschos et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Investigation of a Bicyclo[1.1.1]pentane as a Phenyl Replacement within an LpPLA2 Inhibitor
- (2016) Nicholas D. Measom et al. ACS Medicinal Chemistry Letters
- A previously unreported impact of a PLA2G7 gene polymorphism on the plasma levels of lipoprotein-associated phospholipase A2 activity and mass
- (2016) Yue Qi et al. Scientific Reports
- Genetic invalidation of Lp-PLA2 as a therapeutic target: Large-scale study of five functional Lp-PLA2-lowering alleles
- (2016) John M Gregson et al. European Journal of Preventive Cardiology
- Lipoprotein‐Associated Phospholipase A2Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease
- (2016) Lars Wallentin et al. Journal of the American Heart Association
- Use of Plasma Metabolomics to Identify Diagnostic Biomarkers for Early Stage Epithelial Ovarian Cancer
- (2016) Lijun Fan et al. Journal of Cancer
- Role of Inflammasome Activation in the Pathophysiology of Vascular Diseases of the Neurovascular Unit
- (2015) Islam N. Mohamed et al. ANTIOXIDANTS & REDOX SIGNALING
- A rationally designed mutant of plasma platelet-activating factor acetylhydrolase hydrolyzes the organophosphorus nerve agent soman
- (2015) Stephen D. Kirby et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Prostacyclin Prevents Pericyte Loss and Demyelination Induced by Lysophosphatidylcholine in the Central Nervous System
- (2015) Rieko Muramatsu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lipoprotein-associated phospholipase A2 single-nucleotide polymorphisms and cardiovascular events in patients with coronary artery disease
- (2015) Giuseppe Maiolino et al. Journal of Cardiovascular Medicine
- Discovery of a Novel Series of Imidazo[1,2-a]pyrimidine Derivatives as Potent and Orally Bioavailable Lipoprotein-Associated Phospholipase A2 Inhibitors
- (2015) Xinde Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Association between polymorphisms in phospholipase A2 genes and the plasma triglyceride response to an n-3 PUFA supplementation: a clinical trial
- (2015) Bénédicte L Tremblay et al. Lipids in Health and Disease
- Nonsynonymous polymorphisms in PLA2G7 gene are associated with the risk of coronary heart disease in a southern Chinese population
- (2015) Mei Hong et al. MAMMALIAN GENOME
- Coronary Heart Disease and Genetic Variants with Low Phospholipase A2 Activity
- (2015) Linda M. Polfus et al. NEW ENGLAND JOURNAL OF MEDICINE
- Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, in Diabetic Macular Edema
- (2015) Giovanni Staurenghi et al. OPHTHALMOLOGY
- Diagnostic marker signature for esophageal cancer from transcriptome analysis
- (2015) Ute Warnecke-Eberz et al. TUMOR BIOLOGY
- Is Lipoprotein-Associated Phospholipase A2 a Link between Inflammation and Subclinical Atherosclerosis in Rheumatoid Arthritis?
- (2015) Anna Södergren et al. Biomed Research International
- Apolipoprotein CIII regulates lipoprotein-associated phospholipase A2 expression via the MAPK and NF B pathways
- (2015) X. Han et al. Biology Open
- Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial
- (2015) Janet Lo et al. Lancet HIV
- The Role of Lipoprotein-Associated Phospholipase A₂ in a Murine Model of Experimental Autoimmune Uveoretinitis
- (2015) G. L. Crawford et al. PLoS One
- Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins
- (2015) Paula Vainio et al. Oncotarget
- Enhanced breast cancer cell adherence to the lung endothelium via PAF acetylhydrolase inhibition: a potential mechanism for enhanced metastasis in smokers
- (2014) Shannon E. Kispert et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study
- (2014) Annette L. Fitzpatrick et al. ATHEROSCLEROSIS
- Association of PLA2G7 gene polymorphisms with ischemic stroke in northern Chinese Han population
- (2014) Xu Liu et al. CLINICAL BIOCHEMISTRY
- Blood mRNA Expression Profiling Predicts Survival in Patients Treated with Tremelimumab
- (2014) Y. Saenger et al. CLINICAL CANCER RESEARCH
- Pathophysiological Role and Clinical Significance of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Bound to LDL and HDL
- (2014) Constantinos Tellis et al. CURRENT PHARMACEUTICAL DESIGN
- Proresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation
- (2014) Christopher D. Buckley et al. IMMUNITY
- Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome
- (2014) Michelle L. O’Donoghue et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- To hydrolyze or not to hydrolyze: the dilemma of platelet-activating factor acetylhydrolase
- (2014) Gopal Kedihitlu Marathe et al. JOURNAL OF LIPID RESEARCH
- Effects of A379V variant of the Lp-PLA 2 gene on Lp-PLA2 activity and markers of oxidative stress and endothelial function in Koreans
- (2014) Jey Sook Chae et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Time course-changes in phosphatidylcholine profile during oxidative modification of low-density lipoprotein
- (2014) Naoko Sasabe et al. Lipids in Health and Disease
- Associations of platelet-activating factor acetylhydrolase (PAF-AH) gene polymorphisms with circulating PAF-AH levels and risk of coronary heart disease or blood stasis syndrome in the Chinese Han population
- (2014) Guo-Hua Zheng et al. MOLECULAR BIOLOGY REPORTS
- GSK's darapladib failures dim hopes for anti-inflammatory heart drugs
- (2014) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Platelet Aggregation Unchanged by Lipoprotein-Associated Phospholipase A2 Inhibition: Results from an In Vitro Study and Two Randomized Phase I Trials
- (2014) Bonnie C. Shaddinger et al. PLoS One
- Guidelines for the Primary Prevention of Stroke
- (2014) James F. Meschia et al. STROKE
- Nitro-oleic acid downregulates lipoprotein-associated phospholipase A2 expression via the p42/p44 MAPK and NFκB pathways
- (2014) Gangqi Wang et al. Scientific Reports
- Diabetic macular edema: new concepts in patho-physiology and treatment
- (2014) Xinyuan Zhang et al. Cell and Bioscience
- Serum amyloid A stimulates lipoprotein-associated phospholipase A2 expression in vitro and in vivo
- (2013) Bo Li et al. ATHEROSCLEROSIS
- Design and synthesis of imidazole and triazole derivatives as Lp-PLA2 inhibitors and the unexpected discovery of highly potent quaternary ammonium salts
- (2013) Kai Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Triazole derivatives: A series of Darapladib analogues as orally active Lp-PLA2 inhibitors
- (2013) Kai Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Deficiency of Phospholipase A2 Group 7 Decreases Intestinal Polyposis and Colon Tumorigenesis in ApcMin/+ Mice
- (2013) C. Xu et al. CANCER RESEARCH
- Effect of Darapladib on Plasma Lipoprotein-Associated Phospholipase A2 Activity in Japanese Dyslipidemic Patients, With Exploratory Analysis of a PLA2G7 Gene Polymorphism of Val279Phe
- (2013) Hiroyuki Daida et al. CIRCULATION JOURNAL
- Lipoprotein-Associated Phospholipase A2, a Novel Cardiovascular Inflammatory Marker, in HIV-Infected Patients
- (2013) A. Mangili et al. CLINICAL INFECTIOUS DISEASES
- New Therapeutic Targets for Calcific Aortic Valve Stenosis
- (2013) Ming-Yow Hung et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Elevated Expression of Lipoprotein-Associated Phospholipase A2 in Calcific Aortic Valve Disease
- (2013) Ablajan Mahmut et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Elevated PLA2G7 Gene Promoter Methylation as a Gender-Specific Marker of Aging Increases the Risk of Coronary Heart Disease in Females
- (2013) Danjie Jiang et al. PLoS One
- An association study between genetic polymorphisms related to lipoprotein-associated phospholipase A2 and coronary heart disease
- (2013) LIMIN XU et al. Experimental and Therapeutic Medicine
- Changes in Lipoprotein‐Associated Phospholipase A2 Activity Predict Coronary Events and Partly Account for the Treatment Effect of Pravastatin: Results From the Long‐term Intervention with Pravastatin in Ischemic Disease Study
- (2013) Harvey D. White et al. Journal of the American Heart Association
- The prevalence of platelet activating factor acetylhydrolase single nucleotide polymorphisms in relationship to necrotizing enterocolitis in Northwest Louisiana infants
- (2013) Senthilkumar Sankararaman et al. SpringerPlus
- Biomarkers for Insulin Resistance and Inflammation and the Risk for All-Cause Dementia and Alzheimer Disease
- (2012) Thomas M. van Himbergen ARCHIVES OF NEUROLOGY
- Nrf3-Pla2g7 Interaction Plays an Essential Role in Smooth Muscle Differentiation From Stem Cells
- (2012) Qingzhong Xiao et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Specificity of Lipoprotein-Associated Phospholipase A2 toward Oxidized Phosphatidylserines: Liquid Chromatography–Electrospray Ionization Mass Spectrometry Characterization of Products and Computer Modeling of Interactions
- (2012) Vladimir A. Tyurin et al. BIOCHEMISTRY
- Amides of 4-hydroxy-8-methanesulfonylamino-quinoline-2-carboxylic acid as zinc-dependent inhibitors of Lp-PLA2
- (2012) Yi Hu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Selective inhibitors and tailored activity probes for lipoprotein-associated phospholipase A2
- (2012) Joseph M.G. Nagano et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Translational Studies of Lipoprotein-Associated Phospholipase A2 in Inflammation and Atherosclerosis
- (2012) Jane F. Ferguson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- DAGLβ inhibition perturbs a lipid network involved in macrophage inflammatory responses
- (2012) Ku-Lung Hsu et al. Nature Chemical Biology
- Macrophage VLDL receptor promotes PAFAH secretion in mother's milk and suppresses systemic inflammation in nursing neonates
- (2012) Yang Du et al. Nature Communications
- Plasma lipoprotein-associated phospholipase A2 activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional study
- (2012) Julie E Davidson et al. Alzheimers Research & Therapy
- Lipoprotein-associated phospholipase A2 (Lp-PLA2) and risk of dementia in the cardiovascular health study
- (2011) Annette Fitzpatrick et al. Alzheimers & Dementia
- Study design and rationale for the Stabilization of pLaques usIng Darapladib—Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome
- (2011) Michelle L. O'Donoghue et al. AMERICAN HEART JOURNAL
- Arachidonic Acid Pathway Members PLA2G7, HPGD, EPHX2, and CYP4F8 Identified as Putative Novel Therapeutic Targets in Prostate Cancer
- (2011) Paula Vainio et al. AMERICAN JOURNAL OF PATHOLOGY
- Genetic and environmental regulation of inflammatory CVD biomarkers Lp-PLA2 and IgM anti-PC
- (2011) Iffat Rahman et al. ATHEROSCLEROSIS
- Lipoprotein-Associated Phospholipase A2Interacts with Phospholipid Vesicles via a Surface-Disposed Hydrophobic α-Helix
- (2011) Jian Cao et al. BIOCHEMISTRY
- Amides of xanthurenic acid as zinc-dependent inhibitors of Lp-PLA2
- (2011) Emme C.K. Lin et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
- (2011) Edward A. Dennis et al. CHEMICAL REVIEWS
- Eight genetic loci associated with variation in lipoprotein-associated phospholipase A2 mass and activity and coronary heart disease: meta-analysis of genome-wide association studies from five community-based studies
- (2011) H. Grallert et al. EUROPEAN HEART JOURNAL
- Lipopolysaccharide and platelet-activating factor stimulate expression of platelet-activating factor acetylhydrolase via distinct signaling pathways
- (2011) Katherine M. Howard et al. INFLAMMATION RESEARCH
- Genetic determinants of platelet reactivity during acetylsalicylic acid therapy in diabetic patients: evaluation of 27 polymorphisms within candidate genes
- (2011) M. POSTULA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Association of Serum Lipoprotein-Associated Phospholipase A2 Level with Nonalcoholic Fatty Liver Disease
- (2011) Yasar Colak et al. Metabolic Syndrome and Related Disorders
- Sequencing of Lp-PLA2-encoding PLA2G7 gene in 2000 Europeans reveals several rare loss-of-function mutations
- (2011) K Song et al. PHARMACOGENOMICS JOURNAL
- Carriage of the V279F Null Allele within the Gene Encoding Lp-PLA2 Is Protective from Coronary Artery Disease in South Korean Males
- (2011) Yangsoo Jang et al. PLoS One
- Inflammation in diabetic retinopathy
- (2011) Johnny Tang et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease
- (2010) Harvey White et al. AMERICAN HEART JOURNAL
- Naturally occurring human plasminogen, like genetically related apolipoprotein(a), contains oxidized phosphatidylcholine adducts
- (2010) Celina Edelstein et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Membrane lipid composition differentially modulates the function of human plasma platelet activating factor-acetylhydrolase
- (2010) Abhay H. Pande et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- PLA2G7 Genotype, Lipoprotein-Associated Phospholipase A 2 Activity, and Coronary Heart Disease Risk in 10 494 Cases and 15 624 Controls of European Ancestry
- (2010) Juan P. Casas et al. CIRCULATION
- Circulating Platelet-Activating Factor Is Primarily Cleared by Transport, Not Intravascular Hydrolysis by Lipoprotein-Associated Phospholipase A 2 / PAF Acetylhydrolase
- (2010) Jinbo Liu et al. CIRCULATION RESEARCH
- Lipoprotein-Associated Phospholipase A2 Activity and Incident Coronary Heart Disease Among Men and Women With Type 2 Diabetes
- (2010) I. J. Hatoum et al. DIABETES
- Identification of the G994T polymorphism in exon 9 of plasma platelet-activating factor acetylhydrolase gene as a risk factor for polycystic ovary syndrome
- (2010) Ping Fan et al. HUMAN REPRODUCTION
- Mouse Plasminogen Has Oxidized Phosphatidylcholine Adducts That Are Not Metabolized by Lipoprotein-Associated Phospholipase A2 under Basal Conditions
- (2010) Celina Edelstein et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Simvastatin Reduces Lipoprotein-associated Phospholipase A2 in Lipopolysaccharide-stimulated Human Monocyte–derived Macrophages Through Inhibition of the Mevalonate–Geranylgeranyl Pyrophosphate–RhoA-p38 Mitogen-activated Protein Kinase Pathway
- (2010) Jun-Xian Song et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Lipoprotein-associated phospholipase A2 gene V279F polymorphisms and coronary heart disease: a meta-analysis
- (2010) Guo-Hua Zheng et al. MOLECULAR BIOLOGY REPORTS
- Decrease of Plasma Platelet-Activating Factor Acetylhydrolase Activity in Lipopolysaccharide Induced Mongolian Gerbil Sepsis Model
- (2010) Junwei Yang et al. PLoS One
- PLA2G7 gene polymorphisms and coronary heart disease risk: A meta-analysis
- (2010) Qianqian Wang et al. THROMBOSIS RESEARCH
- Genome-Wide Association Study of Lp-PLA2 Activity and Mass in the Framingham Heart Study
- (2010) Sunil Suchindran et al. PLoS Genetics
- Crystal structures of human group-VIIA phospholipase A2 inhibited by organophosphorus nerve agents exhibit non-aged complexes
- (2009) Uttamkumar Samanta et al. BIOCHEMICAL PHARMACOLOGY
- Inflammatory cytokines in vascular dysfunction and vascular disease
- (2009) Alexander H. Sprague et al. BIOCHEMICAL PHARMACOLOGY
- Lipoprotein-associated phospholipase A2 decreases oxidized lipoprotein cellular association by human macrophages and hepatocytes
- (2009) Ming Yang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- PAF-acetylhydrolase expressed during megakaryocyte differentiation inactivates PAF-like lipids
- (2009) J. M. Foulks et al. BLOOD
- OxLDL stimulates lipoprotein-associated phospholipase A2 expression in THP-1 monocytes via PI3K and p38 MAPK pathways
- (2009) Wen-Yi Wang et al. CARDIOVASCULAR RESEARCH
- Lipoprotein-associated phospholipase A2, a marker of vascular inflammation and systemic vulnerability
- (2009) T. Munzel et al. EUROPEAN HEART JOURNAL
- Darapladib
- (2009) Quang T Bui et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Association of PLA2G7 polymorphisms with carotid atherosclerosis in hypertensive Japanese
- (2009) Yoshikazu Miwa et al. HYPERTENSION RESEARCH
- Crystallization and Preliminary X-Ray Crystallographic Analysis of Human Plasma Platelet Activating Factor Acetylhydrolase
- (2009) Uttamkumar Samanta et al. PROTEIN AND PEPTIDE LETTERS
- Physiology and Function of the Tight Junction
- (2009) J. M. Anderson et al. Cold Spring Harbor Perspectives in Biology
- A twin study of heritability of plasma lipoprotein-associated phospholipase A2 (Lp-PLA2) mass and activity
- (2008) Livia Lenzini et al. ATHEROSCLEROSIS
- Biology of Platelet-activating Factor Acetylhydrolase (PAF-AH, Lipoprotein Associated Phospholipase A2)
- (2008) Diana M. Stafforini CARDIOVASCULAR DRUGS AND THERAPY
- Comprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case–control and family datasets
- (2008) Beth S. Sutton et al. HUMAN MOLECULAR GENETICS
- Identification of a Domain That Mediates Association of Platelet-activating Factor Acetylhydrolase with High Density Lipoprotein
- (2008) Alison A. Gardner et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Crystal Structure of Human Plasma Platelet-activating Factor Acetylhydrolase
- (2008) Uttamkumar Samanta et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Platelet-activating factor acetylhydrolase and transacetylase activities in human aorta and mammary artery
- (2008) Demokritos C. Tsoukatos et al. JOURNAL OF LIPID RESEARCH
- Genetic variants and haplotypes of lipoprotein associated phospholipase A2 and their influence on cardiovascular disease (The Ludwigshafen Risk and Cardiovascular Health Study)
- (2008) M. M. HOFFMANN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype
- (2008) Helene R. McMurray et al. NATURE
- The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
- (2008) Berislav V. Zlokovic NEURON
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started